This website is no longer being updated. Please visit GBCHealth’s new website at:



Bristol-Myers Squibb Foundation Awards New Grants for Hepatitis in China and India

The Bristol-Myers Squibb Foundation this week awarded four grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatitis C (HCV) in China and India. The foundation marked World Hepatitis Day, July 27, by awarding these grants as part of its Delivering Hope program.

The recipients of the new grants – the China Foundation for Hepatitis Prevention and Control, the HOPE Initiative, the Liver Foundation West Bengal, and a coalition that includes the United Way of Mumbai, the National Liver Foundation and AmeriCares India – are long-term partners of Delivering Hope which improves awareness, care and support for hepatitis B and C in China and India.

China and India together have an estimated 123 million people chronically infected with hepatitis B and 59 million people chronically infected with hepatitis C, accounting for almost 50 percent of all HBV and HCV infections worldwide.

See the press release here.